Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Tropisetron × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1

Interventions

Saline Solution 25 Metformin 23 Zoledronic Acid 22 Dexamethasone 21 Cytarabine 19 Cyclophosphamide 19 Bupivacaine 18 Sodium Chloride 17 Letrozole 16 Propofol 15 Vincristine 14 Morphine 14 Methotrexate 14 Dexmedetomidine 14 Fentanyl 13 Bevacizumab 13 Imiquimod 12 Doxorubicin 12 Docetaxel 12 Prednisolone 11 Oxycodone 11 Mercaptopurine 11 Cisplatin 11 Capecitabine 11 Ropivacaine 10 Rituximab 10 Prednisone 10 Granulocyte Colony-Stimulating Factor 10 Everolimus 10 Acetaminophen 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡